Sarah M. Ruttenberg, , , Joshua M. Rowe, , and , Alireza Abdolvahabi*,
{"title":"Quantifying Hydrolytic Enzymes in the Vitreous Humor of Humans and Nonhuman Species Using Targeted Proteomics","authors":"Sarah M. Ruttenberg, , , Joshua M. Rowe, , and , Alireza Abdolvahabi*, ","doi":"10.1021/acs.jproteome.5c00208","DOIUrl":null,"url":null,"abstract":"<p >The vitreous humor is a viscous ocular fluid that contains a complex proteome including hydrolytic enzymes. Differences between concentrations of these enzymes may contribute to the variable hydrolysis of some intravitreal drugs/implants. Here, we developed a targeted proteomics method to quantify six hydrolytic enzymes in the vitreous humor of eight human donors as well as in the vitreous humor of rabbits, minipigs, and monkeys. These enzymes include cathepsin D (CTSD), ectonucleotide pyrophosphatase 2 (ENPP2), B-hexosaminidase subunit alpha (HEXA), serum paraoxonase 1 (PON1), tripeptidyl peptidase 1 (TPP1), and ubiquitin carboxy-terminal hydrolase lysozyme 1 (UCHL1). The results showed that enzyme concentrations were different among human subjects and between nonhuman species. Within human samples, CTSD and ENPP2 showed the highest levels. A gender-based comparison also revealed that two enzymes, UCHL1 and TPP1, showed significantly higher levels in female subjects compared to those in male subjects. Comparisons between humans and other species revealed potentially significant inter- and intraspecies differences between the levels of hydrolytic enzymes. Although performed on a limited number of samples to draw a robust biological conclusion, these results can guide researchers in the design of <i>in vitro</i> models of vitreous humor for prodrug metabolism and implant polymer degradation studies.</p>","PeriodicalId":48,"journal":{"name":"Journal of Proteome Research","volume":"24 10","pages":"5297–5304"},"PeriodicalIF":3.6000,"publicationDate":"2025-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Proteome Research","FirstCategoryId":"99","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acs.jproteome.5c00208","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0
Abstract
The vitreous humor is a viscous ocular fluid that contains a complex proteome including hydrolytic enzymes. Differences between concentrations of these enzymes may contribute to the variable hydrolysis of some intravitreal drugs/implants. Here, we developed a targeted proteomics method to quantify six hydrolytic enzymes in the vitreous humor of eight human donors as well as in the vitreous humor of rabbits, minipigs, and monkeys. These enzymes include cathepsin D (CTSD), ectonucleotide pyrophosphatase 2 (ENPP2), B-hexosaminidase subunit alpha (HEXA), serum paraoxonase 1 (PON1), tripeptidyl peptidase 1 (TPP1), and ubiquitin carboxy-terminal hydrolase lysozyme 1 (UCHL1). The results showed that enzyme concentrations were different among human subjects and between nonhuman species. Within human samples, CTSD and ENPP2 showed the highest levels. A gender-based comparison also revealed that two enzymes, UCHL1 and TPP1, showed significantly higher levels in female subjects compared to those in male subjects. Comparisons between humans and other species revealed potentially significant inter- and intraspecies differences between the levels of hydrolytic enzymes. Although performed on a limited number of samples to draw a robust biological conclusion, these results can guide researchers in the design of in vitro models of vitreous humor for prodrug metabolism and implant polymer degradation studies.
期刊介绍:
Journal of Proteome Research publishes content encompassing all aspects of global protein analysis and function, including the dynamic aspects of genomics, spatio-temporal proteomics, metabonomics and metabolomics, clinical and agricultural proteomics, as well as advances in methodology including bioinformatics. The theme and emphasis is on a multidisciplinary approach to the life sciences through the synergy between the different types of "omics".